Supplementary Figure S7 from SARC028 Samples Reveal an Interplay between TGF-β, IFN Signaling, and Low HLA Class I Expression as Contributors to Ewing Sarcoma Checkpoint Blockade Resistance Article Swipe
Jessica D. Daley
,
Elina Mukherjee
,
David Ferraro
,
Shanthi Bhaskar
,
Anthony Green
,
E. Michael Meyer
,
Hussein A. Tawbi
,
Melissa Burgess
,
Tullia C. Bruno
,
Anthony R. Cillo
,
Kelly M. Bailey
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.30028540
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.30028540
Supplementary Figure S7. Spatial distribution of cells from each patient tumor biopsy and enumeration of the proportion of cells with in each spatially resolved cell neighborhoods in each biopsy.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.30028540
- https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S7_from_SARC028_Samples_Reveal_an_Interplay_between_TGF-_IFN_Signaling_and_Low_HLA_Class_I_Expression_as_Contributors_to_Ewing_Sarcoma_Checkpoint_Blockade_Resistance/30028540/1/files/57576844.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4413906152
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4413906152Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.30028540Digital Object Identifier
- Title
-
Supplementary Figure S7 from SARC028 Samples Reveal an Interplay between TGF-β, IFN Signaling, and Low HLA Class I Expression as Contributors to Ewing Sarcoma Checkpoint Blockade ResistanceWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-02Full publication date if available
- Authors
-
Jessica D. Daley, Elina Mukherjee, David Ferraro, Shanthi Bhaskar, Anthony Green, E. Michael Meyer, Hussein A. Tawbi, Melissa Burgess, Tullia C. Bruno, Anthony R. Cillo, Kelly M. BaileyList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.30028540Publisher landing page
- PDF URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S7_from_SARC028_Samples_Reveal_an_Interplay_between_TGF-_IFN_Signaling_and_Low_HLA_Class_I_Expression_as_Contributors_to_Ewing_Sarcoma_Checkpoint_Blockade_Resistance/30028540/1/files/57576844.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S7_from_SARC028_Samples_Reveal_an_Interplay_between_TGF-_IFN_Signaling_and_Low_HLA_Class_I_Expression_as_Contributors_to_Ewing_Sarcoma_Checkpoint_Blockade_Resistance/30028540/1/files/57576844.pdfDirect OA link when available
- Concepts
-
Blockade, Ewing's sarcoma, Cancer research, Transforming growth factor, Immune checkpoint, Expression (computer science), Sarcoma, Biology, Cell biology, Medicine, Genetics, Computer science, Receptor, Pathology, Programming languageTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4413906152 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.30028540 |
| ids.doi | https://doi.org/10.1158/1078-0432.30028540 |
| ids.openalex | https://openalex.org/W4413906152 |
| fwci | 0.0 |
| type | article |
| title | Supplementary Figure S7 from SARC028 Samples Reveal an Interplay between TGF-β, IFN Signaling, and Low HLA Class I Expression as Contributors to Ewing Sarcoma Checkpoint Blockade Resistance |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10335 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9585000276565552 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Colorectal Cancer Surgical Treatments |
| topics[1].id | https://openalex.org/T10158 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9562000036239624 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Immunotherapy and Biomarkers |
| topics[2].id | https://openalex.org/T11369 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9398000240325928 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2734 |
| topics[2].subfield.display_name | Pathology and Forensic Medicine |
| topics[2].display_name | Genetic factors in colorectal cancer |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778468042 |
| concepts[0].level | 3 |
| concepts[0].score | 0.6831827759742737 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q273976 |
| concepts[0].display_name | Blockade |
| concepts[1].id | https://openalex.org/C2777586341 |
| concepts[1].level | 3 |
| concepts[1].score | 0.5368808507919312 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1138580 |
| concepts[1].display_name | Ewing's sarcoma |
| concepts[2].id | https://openalex.org/C502942594 |
| concepts[2].level | 1 |
| concepts[2].score | 0.49951624870300293 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[2].display_name | Cancer research |
| concepts[3].id | https://openalex.org/C118131993 |
| concepts[3].level | 2 |
| concepts[3].score | 0.43922698497772217 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q423671 |
| concepts[3].display_name | Transforming growth factor |
| concepts[4].id | https://openalex.org/C2780851360 |
| concepts[4].level | 4 |
| concepts[4].score | 0.41373389959335327 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q21686041 |
| concepts[4].display_name | Immune checkpoint |
| concepts[5].id | https://openalex.org/C90559484 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4129670560359955 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q778379 |
| concepts[5].display_name | Expression (computer science) |
| concepts[6].id | https://openalex.org/C2778256501 |
| concepts[6].level | 2 |
| concepts[6].score | 0.400826096534729 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q223911 |
| concepts[6].display_name | Sarcoma |
| concepts[7].id | https://openalex.org/C86803240 |
| concepts[7].level | 0 |
| concepts[7].score | 0.3605976700782776 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[7].display_name | Biology |
| concepts[8].id | https://openalex.org/C95444343 |
| concepts[8].level | 1 |
| concepts[8].score | 0.29004284739494324 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[8].display_name | Cell biology |
| concepts[9].id | https://openalex.org/C71924100 |
| concepts[9].level | 0 |
| concepts[9].score | 0.23626887798309326 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[9].display_name | Medicine |
| concepts[10].id | https://openalex.org/C54355233 |
| concepts[10].level | 1 |
| concepts[10].score | 0.2203255593776703 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[10].display_name | Genetics |
| concepts[11].id | https://openalex.org/C41008148 |
| concepts[11].level | 0 |
| concepts[11].score | 0.11048427224159241 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[11].display_name | Computer science |
| concepts[12].id | https://openalex.org/C170493617 |
| concepts[12].level | 2 |
| concepts[12].score | 0.10450899600982666 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[12].display_name | Receptor |
| concepts[13].id | https://openalex.org/C142724271 |
| concepts[13].level | 1 |
| concepts[13].score | 0.06939554214477539 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[13].display_name | Pathology |
| concepts[14].id | https://openalex.org/C199360897 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q9143 |
| concepts[14].display_name | Programming language |
| keywords[0].id | https://openalex.org/keywords/blockade |
| keywords[0].score | 0.6831827759742737 |
| keywords[0].display_name | Blockade |
| keywords[1].id | https://openalex.org/keywords/ewings-sarcoma |
| keywords[1].score | 0.5368808507919312 |
| keywords[1].display_name | Ewing's sarcoma |
| keywords[2].id | https://openalex.org/keywords/cancer-research |
| keywords[2].score | 0.49951624870300293 |
| keywords[2].display_name | Cancer research |
| keywords[3].id | https://openalex.org/keywords/transforming-growth-factor |
| keywords[3].score | 0.43922698497772217 |
| keywords[3].display_name | Transforming growth factor |
| keywords[4].id | https://openalex.org/keywords/immune-checkpoint |
| keywords[4].score | 0.41373389959335327 |
| keywords[4].display_name | Immune checkpoint |
| keywords[5].id | https://openalex.org/keywords/expression |
| keywords[5].score | 0.4129670560359955 |
| keywords[5].display_name | Expression (computer science) |
| keywords[6].id | https://openalex.org/keywords/sarcoma |
| keywords[6].score | 0.400826096534729 |
| keywords[6].display_name | Sarcoma |
| keywords[7].id | https://openalex.org/keywords/biology |
| keywords[7].score | 0.3605976700782776 |
| keywords[7].display_name | Biology |
| keywords[8].id | https://openalex.org/keywords/cell-biology |
| keywords[8].score | 0.29004284739494324 |
| keywords[8].display_name | Cell biology |
| keywords[9].id | https://openalex.org/keywords/medicine |
| keywords[9].score | 0.23626887798309326 |
| keywords[9].display_name | Medicine |
| keywords[10].id | https://openalex.org/keywords/genetics |
| keywords[10].score | 0.2203255593776703 |
| keywords[10].display_name | Genetics |
| keywords[11].id | https://openalex.org/keywords/computer-science |
| keywords[11].score | 0.11048427224159241 |
| keywords[11].display_name | Computer science |
| keywords[12].id | https://openalex.org/keywords/receptor |
| keywords[12].score | 0.10450899600982666 |
| keywords[12].display_name | Receptor |
| keywords[13].id | https://openalex.org/keywords/pathology |
| keywords[13].score | 0.06939554214477539 |
| keywords[13].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.30028540 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S7_from_SARC028_Samples_Reveal_an_Interplay_between_TGF-_IFN_Signaling_and_Low_HLA_Class_I_Expression_as_Contributors_to_Ewing_Sarcoma_Checkpoint_Blockade_Resistance/30028540/1/files/57576844.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.30028540 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5071762102 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5133-448X |
| authorships[0].author.display_name | Jessica D. Daley |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jessica D. Daley |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5087310423 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9750-7219 |
| authorships[1].author.display_name | Elina Mukherjee |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Elina Mukherjee |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5006786633 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | David Ferraro |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | David Ferraro |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5111193563 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Shanthi Bhaskar |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Shanthi Bhaskar |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5079584736 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-5805-3004 |
| authorships[4].author.display_name | Anthony Green |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Anthony Green |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5110779086 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | E. Michael Meyer |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Ernest M. Meyer |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5000768609 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-1942-851X |
| authorships[6].author.display_name | Hussein A. Tawbi |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Hussain Tawbi |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5088270651 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-5753-1422 |
| authorships[7].author.display_name | Melissa Burgess |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Melissa Burgess |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5044898944 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-6433-0207 |
| authorships[8].author.display_name | Tullia C. Bruno |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Tullia C. Bruno |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5091187053 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-3213-3129 |
| authorships[9].author.display_name | Anthony R. Cillo |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Anthony R. Cillo |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5078981831 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-3925-3243 |
| authorships[10].author.display_name | Kelly M. Bailey |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Kelly M. Bailey |
| authorships[10].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S7_from_SARC028_Samples_Reveal_an_Interplay_between_TGF-_IFN_Signaling_and_Low_HLA_Class_I_Expression_as_Contributors_to_Ewing_Sarcoma_Checkpoint_Blockade_Resistance/30028540/1/files/57576844.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Figure S7 from SARC028 Samples Reveal an Interplay between TGF-β, IFN Signaling, and Low HLA Class I Expression as Contributors to Ewing Sarcoma Checkpoint Blockade Resistance |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10335 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9585000276565552 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Colorectal Cancer Surgical Treatments |
| related_works | https://openalex.org/W2182789434, https://openalex.org/W2078405839, https://openalex.org/W4393219064, https://openalex.org/W3171040582, https://openalex.org/W2347767060, https://openalex.org/W3212375017, https://openalex.org/W2263980547, https://openalex.org/W4379537877, https://openalex.org/W2085972006, https://openalex.org/W2040042473 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1078-0432.30028540 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S7_from_SARC028_Samples_Reveal_an_Interplay_between_TGF-_IFN_Signaling_and_Low_HLA_Class_I_Expression_as_Contributors_to_Ewing_Sarcoma_Checkpoint_Blockade_Resistance/30028540/1/files/57576844.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.30028540 |
| primary_location.id | doi:10.1158/1078-0432.30028540 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S7_from_SARC028_Samples_Reveal_an_Interplay_between_TGF-_IFN_Signaling_and_Low_HLA_Class_I_Expression_as_Contributors_to_Ewing_Sarcoma_Checkpoint_Blockade_Resistance/30028540/1/files/57576844.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.30028540 |
| publication_date | 2025-09-02 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.in | 20, 26 |
| abstract_inverted_index.of | 5, 14, 17 |
| abstract_inverted_index.S7. | 2 |
| abstract_inverted_index.and | 12 |
| abstract_inverted_index.the | 15 |
| abstract_inverted_index.cell | 24 |
| abstract_inverted_index.each | 8, 21, 27 |
| abstract_inverted_index.from | 7 |
| abstract_inverted_index.with | 19 |
| abstract_inverted_index.cells | 6, 18 |
| abstract_inverted_index.tumor | 10 |
| abstract_inverted_index.Figure | 1 |
| abstract_inverted_index.biopsy | 11 |
| abstract_inverted_index.Spatial | 3 |
| abstract_inverted_index.patient | 9 |
| abstract_inverted_index.resolved | 23 |
| abstract_inverted_index.spatially | 22 |
| abstract_inverted_index.proportion | 16 |
| abstract_inverted_index.enumeration | 13 |
| abstract_inverted_index.distribution | 4 |
| abstract_inverted_index.neighborhoods | 25 |
| abstract_inverted_index.biopsy.</p> | 28 |
| abstract_inverted_index.<p>Supplementary | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 11 |
| citation_normalized_percentile.value | 0.51489799 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |